Insulin-like Growth Factor (IGF)-II regulates CCAAT/enhancer binding protein α expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines

Journal of Cellular Biochemistry

Volumn 102, Issue 1, 2007, Pages 161-170

  Tomizawa, Minoru ^a,b   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Insulin like growth factor II; Luciferase assay; LY294002; Mitogen activated protein kinase; Northern blot; PD98059

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BROXURIDINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DACTINOMYCIN; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SCATTER FACTOR; SOMATOMEDIN B; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL; LIVER DEVELOPMENT; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; MORPHOLINES; PROMOTER REGIONS (GENETICS); RNA STABILITY; UP-REGULATION;

EID: 34548509194     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21293     Document Type: Article

References (19)

1. Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM. 1986. Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J Biol Chem 261:13144-13150.
2. DeChiara TM, Robertson EJ, Efstratiadis A. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859.
3. Hopfner M, Huether A, Sutter AP, Baradari V, Schuppan D, Scherubl H. 2006. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Biochem Pharmacol 71:1435-1448.
4. Ishak KG, Glunz PR. 1967. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 20:396-422.
5. Klinz F, Bloch W, Addicks K, Hescheler J. 1999. Inhibition of phosphatidylinositol-3-kinase blocks development of functional embryonic cardiomyocytes. Exp Cell Res 247: 79-83.
6. Kuo CF, Xanthopoulos KG, Darnell JE, Jr. 1990. Fetal and adult localization of C/EBP: Evidence for combinatorial action of transcription factors in cell-specific gene expression. Development 109:473-481.
7. LeRoith D, Roberts CT, Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett 195:127-137.
8. Li X, Cui H, Sandstedt B, Nordlinder H, Larsson E, Ekstrom TJ. 1996. Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: Developmental relationships of the four promoters. J Endocrinol 149:117-124.
9. Lund P, Schubert D, Niketeghad F, Schirmacher P. 2004. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II. Cancer Lett 206:85-96.
10. Shen CN, Slack JM, Tosh D. 2000. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2: 879-887.
11. Shiojiri N, Takeshita K, Yamasaki H, Iwata T. 2004. Suppression of C/EBP alpha expression in biliary cell differentiation from hepatoblasts during mouse liver development. J Hepatol 41:790-798.
12. Streck RD, Pintar JE. 1992. The embryonic pattern of rat insulin-like growth factor-I gene expression suggests a role in induction and early growth of the liver. Endocrinology 131:2030-2032.
13. Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H. 2003. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 130:2513-2524.
14. Takiguchi M. 1998. The C/EBP family of transcription factors in the liver and other organs. Int J Exp Pathol 79: 369-391.
15. Teratani T, Yamamoto H, Aoyagi K, Sasaki H, Asari A, Quinn G, Sasaki H, Terada M, Ochiya T. 2005. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41:836-846.
16. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ. 1995. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 15: 1192-1202.
17. Tomizawa M, Garfield S, Factor V, Xanthopoulos KG. 1998. Hepatocytes deficient in CCAAT/enhancer binding protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary epithelial cell character. Biochem Biophys Res Commun 249:1-5.
18. Wang GL, Timchenko NA. 2005. Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein. Mol Cell Biol 25: 1325-1338.
19. Wang GL, Iakova P, Wilde M, Awad S, Timchenko NA. 2004. Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev 18:912-925.